VA
AXNX

Vident Advisory’s Axonics, Inc. Common Stock AXNX Stock Holding History

Vident Advisory’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,063
Closed -$228K – 1393
2023
Q3 		$228K Buy
+4,063
New +$229K 0.01% 1045

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Vident Advisory's AXNX Position: Q4 2023 in Review

Vident Advisory sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2023, closing a stake of 4,063 shares — an estimated $228K sold.

Vident Advisory first reported a position in AXNX in Q3 2023 and held it in 1 quarter. The position peaked at $228K in Q3 2023. 230 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

  • Vident Advisory reported no remaining Axonics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Vident Advisory sold 4,063 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $228K.
  • Vident Advisory first reported a position in Axonics, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Vident Advisory's Axonics, Inc. Common Stock position peaked at $228K in Q3 2023.
  • 230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on Vident Advisory's 13F filing for Q4 2023, filed 14 Feb 2024.